Welcome Guest | Register / Login

Pharmaceuticals Market Research Reports

The global pharmaceutical market has persistently experienced significant growth due to the ever-increasing demand for novel and more effective drugs. The reasons for this steady increase in the demand for drugs worldwide can be attributed to population growth, newer and more complex disease conditions, ageing population, and the increased prevalence of chronic and infectious diseases, some of which still remain incurable and fatal. Such numerous unmet needs and high demand rates have triggered the boost in R&D investments by key industry sectors, greatly driving the growth of this i... View more

Sort By
Title Published Price Buy Now
Sports Medicine Companies (Arthrex, Arthrocare, Biomet DePuy Mitek, ConMed Linvatec, Smith & Nephew & Stryker) Revenue Analysis
By Renub Research
Renub Research report titled “Sports Medicine Companies (Arthrex, Arthrocare, Biomet DePuy Mitek, ConMed Linvatec, Smith & Nephew & Stryker) Revenue Analysis” provides key players outlook in Sports Medicine. Company Arthrex acc...
Jun 2016 $ 350
Nigeria Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Nigeria's pharmaceutical market will continue to be viewed as a high-risk proposition for multinational pharmaceutical companies. Rampant corruption, coupled with widespread drug counterfeiting and poor pharmaceutical regulation...
Jun 2016 $ 1295
Colombia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Colombia's deteriorating regulatory regime will continue to limit the country's attractiveness to multinational pharmaceutical companies in the coming years. Despite the country's growing rates of medicine consumption, the incre...
Jun 2016 $ 1295
Global Atopic Dermatitis Market Report: 2016 Edition
By Koncept Analytics
Atopic dermatitis (AD) is a chronic, inflammatory skin disease of unknown origin that usually starts in early infancy, but also affects a substantial number of adults. Atopic dermatitis is a long lasting skin disease that affects a large percentag...
Jun 2016 $ 800
Thailand Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Thailand's private healthcare providers will be well positioned for growth. Supporting this trajectory is the country's popularity as a medical tourism destination, augmenting domestic demand for medical services. Private hospit...
Jun 2016 $ 1295
Spain Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Growth in the Spanish pharmaceutical market will remain slow but steady, despite being an economic outperformer in Western Europe. The ageing population of Spain, and the wider Europe region, will create significant revenue earn...
Jun 2016 $ 1295
Singapore Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Prospects for Singapore's healthcare sector will be robust. Supported by the government's consistent investments into the sector, the country has developed a strong research foundation which will in turn serve to augment Singapo...
Jun 2016 $ 1295
Saudi Arabia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Over the forthcoming years, growth in Saudi Arabia's pharmaceutical and healthcare markets will remain elevated. The government's ongoing commitment to sector development will continue to attract investments from multinational d...
Jun 2016 $ 1295
Russia Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Russia's healthcare market is in a precarious position due to a severe lack of funding and an escalating burden of disease. The country's economic recession will see further pressure placed on the population for provision of car...
Jun 2016 $ 1295
Romania Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: In line with Romania's economic outperformance in Europe, the country's pharmaceutical and healthcare markets will see strong growth given increased consumer spending power and higher healthcare contributions. However, aggressiv...
Jun 2016 $ 1295
Portugal Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Portugal's expansionary budget will continue to support rising domestic consumption indices, which will contribute to modest pharmaceutical market growth rates over a multi-quarter horizon. However, the government will do little...
Jun 2016 $ 1295
Panama Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: The local government's increasing investment in the public healthcare system will significantly improve the population's access to medicines and provide revenue-generating opportunities for pharmaceutical companies. The business...
Jun 2016 $ 1295
Chile Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Chile's government will continue to increase its investment in healthcare and play an increasingly important role in providing greater healthcare coverage to local citizens. This will offer considerable commercial opportunities ...
Jun 2016 $ 1295
Sri Lanka Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Despite Sri Lanka's short-term fiscal challenges, the country's pharmaceutical and healthcare markets will continue to expand over the forecast period. In fact, under the FY2016 budget, the government outlined the construction a...
Jun 2016 $ 1295
Nicaragua Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Nicaragua will continue to be the least attractive pharmaceutical market in Central America due to limited healthcare funding, low per capita pharmaceutical expenditure, a substandard regulation system and socio-cultural prefere...
Jun 2016 $ 1295
Hungary Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Hungary's pharmaceuticals and healthcare market will remain a limited prospect for investment due to the systemic underfunding of the healthcare sector. While improvements to healthcare provision and accessibility are likely to ...
Jun 2016 $ 1295
Hong Kong Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Hong Kong's FY2016/17 budget will be largely positive for the healthcare sector. Additional resources have been committed to develop the administrative region's medical infrastructure, while funding for healthcare programmes and...
Jun 2016 $ 1295
Germany Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Germany's pharmaceutical and healthcare markets will continue to expand over the next ten years, translating into renewed commercial opportunities for drugmakers operating in the country. While patented medicines will continue t...
Jun 2016 $ 1295
Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)
By Daedal Research
Scope of the Report The report titled “Global End Stage Renal Disease (ESRD) Market: Size, Trends and Forecasts (2016-2020)” provides an in-depth analysis of the global ESRD market with detaile...
Jun 2016 $ 1200
The US Testosterone Market Report: 2016 Edition
By Koncept Analytics
Testosterone industry is a prominent segment of the pharmaceutical industry. Testosterone is a steroid hormone which exerts effects on the males throughout life. Testosterone is significant for maintaining muscle bulk, adequate levels of red blood...
Jun 2016 $ 800
Global Intravenous (IV) Iron Drugs Market Report: 2016 Edition
By Koncept Analytics
Iron is vital for multiple bodily functions, most importantly for the production of hemoglobin for red blood cells which are responsible for transporting oxygen in the blood. As an element, the only source of iron is from the diet. There is no way...
Jun 2016 $ 800
Global Spinal Cord Stimulation Market Report: 2016 Edition
By Koncept Analytics
Chronic pain is an unpleasant sense of discomfort that persists or progresses over a long period of time. A chronic back pain can be treated through spinal cord stimulation (SCS) therapy. It is a process that uses soft thin wires with electrical l...
Jun 2016 $ 800
Switzerland Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Most of Switzerland's demographic and economic indicators are favourable towards increased pharmaceutical and healthcare spending. The pensionable population proportion is high and growing, and this will translate into greater d...
Jun 2016 $ 1295
Pakistan Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Healthcare expenditure in Pakistan will grow strongly, albeit from a low base. Central to this trajectory is the rise in household incomes as out-of-pocket health spending remains a dominant source of healthcare financing. This ...
Jun 2016 $ 1295
Oman Pharmaceuticals and Healthcare Report Q3 2016
By Business Monitor International
BMI View: Oman's evolving demographic and epidemiological profile will act as key drivers of growth within the country's pharmaceuticals and healthcare markets over the coming years. We view Oman as having considerable growth potential, s...
Jun 2016 $ 1295